Healthcare -
Biotechnology - NASDAQ - US
$ 103.32
-3.21 %
$ 9.87 B
Market Cap
44.15
P/E
SRPT - OPERATING INCOME
Operating Income SRPT - Sarepta Therapeutics, Inc.
-268 M
LAST VALUE
22.83%
2 YEAR CAGR
4.86%
5 YEAR CAGR
-11.49%
10 YEAR CAGR